TC BioPharm (Holdings) (TC BioPharm (Holdings)) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is TC BioPharm (Holdings) FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. TC BioPharm (Holdings)'s Free Cash Flow for the three months ended in Mar. 2024 was $-3.07 Mil. TC BioPharm (Holdings)'s Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, TC BioPharm (Holdings)'s FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, TC BioPharm (Holdings)'s current FCF Yield % is -164.88%.

The historical rank and industry rank for TC BioPharm (Holdings)'s FCF Margin % or its related term are showing as below:

During the past 5 years, the highest FCF Margin % of TC BioPharm (Holdings) was -183.81%. The lowest was -407.22%. And the median was -274.86%.

TCBP's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -139.09
* Ranked among companies with meaningful FCF Margin % only.

TC BioPharm (Holdings) FCF Margin % Historical Data

The historical data trend for TC BioPharm (Holdings)'s FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TC BioPharm (Holdings) FCF Margin % Chart

TC BioPharm (Holdings) Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

-260.50

-183.80

-289.21

-407.24

TC BioPharm (Holdings) Quarterly Data
	Dec19	Sep20	Dec20	Jun21	Sep21	Dec21	Jun22	Dec22	Mar23	Jun23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of TC BioPharm (Holdings)'s FCF Margin %

For the Biotechnology subindustry, TC BioPharm (Holdings)'s FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TC BioPharm (Holdings)'s FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TC BioPharm (Holdings)'s FCF Margin % distribution charts can be found below:

* The bar in red indicates where TC BioPharm (Holdings)'s FCF Margin % falls into.

TC BioPharm (Holdings) FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

TC BioPharm (Holdings)'s FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-13.613	/	0
	=	%

TC BioPharm (Holdings)'s FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-3.069	/	0
	=	%

TC BioPharm (Holdings) FCF Margin % Related Terms

Thank you for viewing the detailed overview of TC BioPharm (Holdings)'s FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

TC BioPharm (Holdings) (TC BioPharm (Holdings)) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TC BioPharm (Holdings) PLC (NAS:TCBP) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

T0U:Germany

Address

Maxim 1, 2 Parklands Way, Holytown, Motherwell, Scotland, GBR, ML1 4WR

Website

https://www.tcbiopharm.com

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform.

Executives

Renaissance Capital Partners Ltd	10 percent owner	42 SHAD THAMES, LONDON X0 SE1 2YD
Diana Elizabeth Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Kenneth Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD
Mark Edward Randall	10 percent owner	C/O RENAISSANCE CAPITAL PARTNERS LTD, 42 SHAD THAMES, LONDON X0 SE1 2YD